ISA investors! Are these stocks brilliant buys or terrible traps for the global recession?

Looking for a safe harbour during choppy weather? Royston Wild talks up some great stocks to buy as a global recession approaches.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A global recession is approaching at pace. It’s one whose scale will likely have huge social, macroeconomic, and geopolitical implications long beyond the current decade. With this in mind it’s up to ISA investors to shape their stocks portfolios in line with this ‘new normal’.

In this environment I think buying shares in Cranswick (LSE: CWK) is a good idea. Broader retail conditions might suffer during economic downturns but our need for edible goods remains constant. This is why City analysts expect this FTSE 250 meat manufacturer to keep growing earnings through the next three fiscal years at least.

These defensive qualities are reflected in Cranswick’s elevated rating. At current prices it sports a price-to-earnings (P/E) ratio of around 21 times for the financial period to March 2021. But so what? With corporate earnings expected to come under sustained pressure during the post-coronavirus period, firms like this that are able to keep growing earnings are worth their weight in gold.

pink toy piggy money box on yellow background

Set to short circuit?

Conversely, Dixons Carphone (LSE: DC) is a share I think all sensible ISA investors need to avoid at all costs. Trading has been strong for the electricals retailer during the lockdown period but I think it’s only a matter of time before its tills start to fall silent.

On Friday, Samuel Miley, economist at the Centre for Economics and Business Research, summed up my fears in a nutshell. He commented that consumer activity is expected to remain suppressed… with lingering fears over the virus, the continued need for social distancing, and wider economic uncertainty all serving to restrict spending”. He went on to add that household consumption won’t reach pre-crisis levels until the mid-2020s.

The landscape is particularly dangerous for sellers of more expensive products and those that are deemed to be non-essential (TVs, games consoles, cameras and the like). It’s no wonder that City analysts expect annual earnings at Dixons Carphone to fall again despite the sales strength of recent months, then. So I don’t care about the FTSE 250 firm’s low forward P/E ratio of 6 times. It’s far too risky for my liking.

A superior ISA buy

I’d much rather put my investment capital to work with Tristel (LSE: TSTL). This isn’t a share that comes cheap. In fact its forward P/E multiple of around 40 times sails above that of Dixons Carphone. But I reckon this is an appropriate reflection of its exceptional defensive characteristics.

Healthcare shares are some of the safest flight-to-safety shares out there. Suppliers of medical services and drugs tend to be more recession-proof than most other businesses. Tristel, though, could well see demand for its products ignite following the coronavirus crisis. Why? It is a major supplier of disinfectant products that are used in hospitals, doctor surgeries, nursing homes and ambulances.

This is why City brokers expect annual earnings at Tristel to keep rising at mid single-digit percentages through to 2021 at least. This is one brilliant stock for ISA investors seeking peace of mind during the imminent global recession.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »